发明申请
US20210179713A1 ANTI-PD-1 ANTIBODIES, ACTIVATABLE ANTI-PD-1 ANTIBODIES, AND METHODS OF USE THEREOF
有权
基本信息:
- 专利标题： ANTI-PD-1 ANTIBODIES, ACTIVATABLE ANTI-PD-1 ANTIBODIES, AND METHODS OF USE THEREOF
- 申请号：US16725587 申请日：2019-12-23
- 公开(公告)号：US20210179713A1 公开(公告)日：2021-06-17
- 发明人： Kimberly Ann Tipton , James William West , Chanty Mariategue Chan
- 申请人： CytomX Therapeutics, Inc.
- 申请人地址： US CA South San Francisco
- 专利权人： CytomX Therapeutics, Inc.
- 当前专利权人： CytomX Therapeutics, Inc.
- 当前专利权人地址： US CA South San Francisco
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61K47/68 ; A61K39/395 ; C07K16/30
摘要：
The invention relates generally to antibodies that specifically bind programmed cell death protein 1 (PD-1), activatable antibodies that specifically bind to PD-1 and methods of making and using these anti-PD-1 antibodies and anti-PD-1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
IPC结构图谱:
| C | 化学；冶金 |
| --C07 | 有机化学 |
| ----C07K | 肽 |
| ------C07K16/00 | 免疫球蛋白，例如，单克隆或多克隆抗体 |
| --------C07K16/18 | .来自动物或人的抵抗物质 |
| ----------C07K16/28 | ..抗受体，细胞表面抗原或细胞表面决定因子 |